Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Solomon

Showing results (191-200 of 1,643) with videos related to

Pageof 165
Sort By:
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 28, 2006
Equivalence trials and the treatment of fungal infections: correctionJ L Moran, P J Solomon
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|April 1, 2006
Some aspects of the design and monitoring of clinical trialsJ L Moran, P J Solomon
Genes & Development|March 21, 2007
Mad3p, a pseudosubstrate inhibitor of APCCdc20 in the spindle assembly checkpointJanet L Burton, Mark J Solomon
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|June 1, 2007
Statistics in review. Part 2: generalised linear models, time-to-event and time-series analysis, evidence synthesis and clinical trialsJohn L Moran, Patricia J Solomon
Respirology (Carlton, Vic.)|September 17, 2013
Emphysema and pulmonary fibrosis: coincidence or conspiracy?Tristan J Huie, Joshua J Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2013
Reply to K. Bujko and D. Tan et alSamuel Y Ngan, Michael J Solomon
Rheumatic Diseases Clinics of North America|April 4, 2015
Lung disease in rheumatoid arthritisZulma X Yunt, Joshua J Solomon
Journal of Colloid and Interface Science|March 29, 2023
Microdynamics of active particles in defect-rich colloidal crystalsKeara T Saud, Michael J Solomon
Immunology and Allergy Clinics of North America|April 13, 2023
Interstitial Lung Disease: 150 Years of ProgressJoshua J Solomon, Kevin K Brown
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Based on the CROWN Findings, Lorlatinib Should Be the Preferred First-Line Treatment for Patients With Advanced ALK-Positive NSCLCHui Jing Hoe, Benjamin J Solomon
Pageof 165

Showing results (191-200 of 1,643) with videos related to

Sort By:
Pageof 165
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|March 28, 2006
Equivalence trials and the treatment of fungal infections: correctionJ L Moran, P J Solomon
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|April 1, 2006
Some aspects of the design and monitoring of clinical trialsJ L Moran, P J Solomon
Genes & Development|March 21, 2007
Mad3p, a pseudosubstrate inhibitor of APCCdc20 in the spindle assembly checkpointJanet L Burton, Mark J Solomon
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|June 1, 2007
Statistics in review. Part 2: generalised linear models, time-to-event and time-series analysis, evidence synthesis and clinical trialsJohn L Moran, Patricia J Solomon
Respirology (Carlton, Vic.)|September 17, 2013
Emphysema and pulmonary fibrosis: coincidence or conspiracy?Tristan J Huie, Joshua J Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2013
Reply to K. Bujko and D. Tan et alSamuel Y Ngan, Michael J Solomon
Rheumatic Diseases Clinics of North America|April 4, 2015
Lung disease in rheumatoid arthritisZulma X Yunt, Joshua J Solomon
Journal of Colloid and Interface Science|March 29, 2023
Microdynamics of active particles in defect-rich colloidal crystalsKeara T Saud, Michael J Solomon
Immunology and Allergy Clinics of North America|April 13, 2023
Interstitial Lung Disease: 150 Years of ProgressJoshua J Solomon, Kevin K Brown
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Based on the CROWN Findings, Lorlatinib Should Be the Preferred First-Line Treatment for Patients With Advanced ALK-Positive NSCLCHui Jing Hoe, Benjamin J Solomon
Pageof 165